deferoxamine has been researched along with bromodeoxyuridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoehn, H; Poot, M; Rabinovitch, PS | 1 |
| Kang, JK; Kim, DY; Kim, WH; Kwon, OH; Park, S | 1 |
| Iwata, M; Zager, RA | 1 |
| Andrei, G; Boelaert, JR; De Clercq, E; Degraef, C; Heenen, M; Hermans, P; Noel, JC; Simonart, T; Snoeck, R; van den Oord, JJ; Van Vooren, JP | 1 |
4 other study(ies) available for deferoxamine and bromodeoxyuridine
| Article | Year |
|---|---|
Free radical mediated cytotoxicity of desferrioxamine.
Topics: Bisbenzimidazole; Bromodeoxyuridine; Cell Division; Cells, Cultured; Deferoxamine; Fibroblasts; Flow Cytometry; Free Radicals; Humans; Oxygen; Staining and Labeling | 1989 |
The mechanism of antiproliferative effect of desferrioxamine on human hepatoma cell lines.
Topics: Bromodeoxyuridine; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Deferoxamine; Flow Cytometry; Humans; Liver Neoplasms; Tumor Cells, Cultured | 1994 |
Myoglobin inhibits proliferation of cultured human proximal tubular (HK-2) cells.
Topics: Acute Kidney Injury; Bromodeoxyuridine; Cell Death; Cell Division; Cells, Cultured; Cytotoxins; Deferoxamine; DNA; Growth Inhibitors; Humans; Iron; Kidney Tubules, Proximal; Myoglobin; Siderophores; Time Factors | 1996 |
Desferrioxamine enhances AIDS-associated Kaposi's sarcoma tumor development in a xenograft model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Apoptosis; Body Weight; Bromodeoxyuridine; Cell Division; Deferoxamine; Humans; In Situ Nick-End Labeling; Iron; Iron Chelating Agents; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Sarcoma, Kaposi; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |